GEMPHIRE THERAPEUTICS INC's ticker is GEMP and the CUSIP is 36870A108. A total of 29 filers reported holding GEMPHIRE THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $186,000 | -56.0% | 493,781 | -5.5% | 0.05% | -57.0% |
| Q2 2019 | $423,000 | -29.6% | 522,481 | 0.0% | 0.11% | -32.5% |
| Q1 2019 | $601,000 | +47.7% | 522,481 | 0.0% | 0.17% | +28.0% |
| Q4 2018 | $407,000 | -63.0% | 522,481 | -2.0% | 0.13% | -58.6% |
| Q3 2018 | $1,099,000 | -79.7% | 533,381 | +0.2% | 0.32% | -80.2% |
| Q2 2018 | $5,425,000 | +55.4% | 532,381 | -0.7% | 1.61% | +46.9% |
| Q1 2018 | $3,491,000 | -18.6% | 536,281 | -0.5% | 1.10% | -18.7% |
| Q4 2017 | $4,287,000 | -16.3% | 539,188 | 0.0% | 1.35% | -20.2% |
| Q3 2017 | $5,122,000 | -25.8% | 539,188 | 0.0% | 1.69% | -27.3% |
| Q2 2017 | $6,902,000 | -13.4% | 539,188 | -28.9% | 2.32% | -19.4% |
| Q1 2017 | $7,966,000 | – | 758,623 | – | 2.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Exchange Capital Management, Inc. | 758,623 | $7,966,000 | 2.88% |
| Cormorant Asset Management, LP | 952,798 | $10,004,000 | 1.45% |
| DAFNA Capital Management LLC | 52,797 | $554,000 | 0.47% |
| HIGHLAND CAPITAL MANAGEMENT LP | 316,789 | $3,326,000 | 0.17% |
| Cambridge Investment Research Advisors, Inc. | 150,564 | $1,581,000 | 0.03% |
| NORRIS PERNE & FRENCH LLP/MI | 10,463 | $110,000 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 634,246 | $6,660,000 | 0.02% |
| SEGALL BRYANT & HAMILL, LLC | 11,000 | $116,000 | 0.00% |
| Acrospire Investment Management LLC | 400 | $4,000 | 0.00% |
| Advisor Group, Inc. | 5,112 | $54,000 | 0.00% |